Gatti, Alessandro
 Distribuzione geografica
Continente #
EU - Europa 506
NA - Nord America 396
AS - Asia 290
OC - Oceania 12
AF - Africa 1
SA - Sud America 1
Totale 1.206
Nazione #
US - Stati Uniti d'America 390
CN - Cina 186
GB - Regno Unito 171
IT - Italia 87
IE - Irlanda 47
DE - Germania 46
RU - Federazione Russa 44
SG - Singapore 40
SE - Svezia 38
FR - Francia 29
FI - Finlandia 28
IN - India 17
VN - Vietnam 15
AU - Australia 12
IR - Iran 9
KR - Corea 9
ID - Indonesia 8
CA - Canada 5
BE - Belgio 3
UA - Ucraina 3
GR - Grecia 2
HR - Croazia 2
JP - Giappone 2
NL - Olanda 2
RO - Romania 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
HK - Hong Kong 1
PA - Panama 1
PT - Portogallo 1
TG - Togo 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.206
Città #
Southend 154
Chandler 75
Beijing 49
Dublin 47
Singapore 36
Ashburn 33
Ann Arbor 32
New York 24
Verona 21
Woodbridge 21
Houston 20
Jinan 17
Nanjing 15
Helsinki 13
Lawrence 11
Princeton 11
Shenyang 11
Dong Ket 10
Lancaster 10
Wilmington 10
Dearborn 9
Jacksonville 8
Kent 8
Seoul 8
Tianjin 8
Sydney 7
Changsha 6
Zhengzhou 6
Guangzhou 5
Haikou 5
Jakarta 5
Melbourne 5
Milan 5
Tehran 5
Boston 4
Cagliari 4
Chengdu 4
Düsseldorf 4
Hangzhou 4
Jiaxing 4
Munich 4
Vancouver 4
Brussels 3
Dallas 3
Fairfield 3
Fuzhou 3
Hebei 3
Lappeenranta 3
Los Angeles 3
Nanchang 3
Putian 3
San Francisco 3
Sindelfingen 3
Taizhou 3
Trento 3
Athens 2
Chongqing 2
Frankfurt am Main 2
Genova 2
Kuopio 2
Luton 2
Ningbo 2
Norwalk 2
Parma 2
Redwood City 2
Seattle 2
Sprang 2
Timisoara 2
Tokyo 2
Arco 1
Baku 1
Bologna 1
Camisano Vicentino 1
Cerea 1
Clearwater 1
Crotone 1
Dalian 1
Espoo 1
Fremont 1
Henderson 1
Illasi 1
Lanzhou 1
Leawood 1
Lisbon 1
Lomé 1
London 1
Malga Leno 1
Mehlingen 1
Messina 1
Monmouth Junction 1
Nashville 1
Newark 1
Panama City 1
Redmond 1
Riva 1
Santa Clara 1
Siena 1
Tashkent 1
Thiais 1
Torino 1
Totale 840
Nome #
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 138
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 136
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 130
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 120
Isolation, expansion and functional characterization of hPL-expanded hBM-MSC for the treatment of systemic and severe acute Graft-versus-Host Disease 117
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 116
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 113
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 110
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 109
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 66
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 54
Head–neck melanoma: Clinical, histopathological and prognostic features of an Italian multicentric study 20
Totale 1.229
Categoria #
all - tutte 3.832
article - articoli 1.415
book - libri 0
conference - conferenze 2.081
curatela - curatele 0
other - altro 336
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 11 27 4 3 9 22 7 11
2020/2021118 16 14 5 18 9 15 3 0 4 1 17 16
2021/2022115 12 39 3 5 8 0 4 4 1 4 6 29
2022/2023238 12 29 20 33 16 71 2 15 33 2 4 1
2023/2024186 5 12 6 19 16 40 4 17 3 17 45 2
2024/2025140 17 20 30 60 13 0 0 0 0 0 0 0
Totale 1.229